COLLA GIANPAOLO 4
4 · SICOR INC · Filed Jan 26, 2004
Insider Transaction Report
Form 4
SICOR INCscri
COLLA GIANPAOLO
EVP, Italian Operations
Transactions
- Sale
Common Stock
2004-01-21$27.76/sh−15,000$416,400→ 0 total - Sale
Common Stock
2004-01-21$27.76/sh−25,000$694,000→ 0 total - Exercise/Conversion
Common Stock
2004-01-21$9.75/sh+10,000$97,500→ 0 total - Exercise/Conversion
Common Stock
2004-01-21$15.19/sh+15,000$227,850→ 0 total - Exercise/Conversion
Employee Stock Option (right to buy)
2004-01-21−15,000→ 0 totalExercise: $15.19Exp: 2013-03-11→ Common Stock (15,000 underlying) - Sale
Common Stock
2004-01-21$27.60/sh−10,000$276,000→ 0 total - Exercise/Conversion
Employee Stock Option (right to buy)
2004-01-21−10,000→ 0 totalExercise: $9.75Exp: 2010-02-25→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2004-01-21$4.63/sh+25,000$115,625→ 0 total - Exercise/Conversion
Employee Stock Option (right to buy)
2004-01-02−25,000→ 0 totalExercise: $4.63Exp: 2007-07-28→ Common Stock (25,000 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2004-01-21−25,000→ 0 totalExercise: $6.48Exp: 2010-01-25→ Common Stock (25,000 underlying)
Footnotes (6)
- [F1]This option, which provided for daily vesting in equal installments over a four year period beginning on July 28, 1997
- [F2]This option, which provided for daily vesting in equal installments over a four year period beginning on January 25, 2000, accelerated in full upon approval by stockholders of SICOR Inc. of the Agreement and Plan of Merger dated as October 31, 2003, by and among SICOR Inc., Teva Pharmaceutical Industries Limited ("Teva") and a wholly owned subsidiary of Teva."
- [F3]This option, which provided for daily vesting in equal installments over a four year period beginning on February 25, 2000, accelerated in full upon approval by stockholders of SICOR Inc. of the Agreement and Plan of Merger dated as October 31, 2003, by and among SICOR Inc., Teva Pharmaceutical Industries Limited ("Teva") and a wholly owned subsidiary of Teva."
- [F4]This option, which provided for daily vesting in equal installments over a four year period beginning on February 26, 2001, accelerated in full upon approval by stockholders of SICOR Inc. of the Agreement and Plan of Merger dated as October 31, 2003, by and among SICOR Inc., Teva Pharmaceutical Industries Limited ("Teva") and a wholly owned subsidiary of Teva."
- [F5]This option, which provided for daily vesting in equal installments over a four year period beginning on March 8, 2002, accelerated in full upon approval by stockholders of SICOR Inc. of the Agreement and Plan of Merger dated as October 31, 2003, by and among SICOR Inc., Teva Pharmaceutical Industries Limited ("Teva") and a wholly owned subsidiary of Teva."
- [F6]This option, which provided for daily vesting in equal installments over a four year period beginning on March 11, 2003, accelerated in full upon approval by stockholders of SICOR Inc. of the Agreement and Plan of Merger dated as October 31, 2003, by and among SICOR Inc., Teva Pharmaceutical Industries Limited ("Teva") and a wholly owned subsidiary of Teva."